Analysts reaffirmed an outperform rating and highlighted potential merger upside with Afya.
On 18 September 2026, Bradesco BBI reiterated an outperform rating for Brazilian education company Yduqs and raised its target price from R$ 15 to R$ 17. The bank named Yduqs as its top pick in the education sector after raising earnings and cash generation projections.
Bradesco BBI raised its 2027 adjusted net income projection by 4% to R$ 442 million. Estimated cash generation rose 12% to R$ 426 million, supported by lower financial expenses, a lower effective tax rate, and working capital improvements. Operationally, the bank expects net revenue growth to accelerate to 3.7% year over year in the second half of 2026.
The analysts also identified a potential 21% upside for Yduqs shares in a hypothetical all-stock merger with Afya. In that scenario, evaluating medical seats and applying a multiple of 4.0 times enterprise value to EBITDA for non-medical operations, Yduqs would hold 36% of the combined company.
According to Bradesco BBI, Yduqs trades at a projected price-to-earnings multiple of 5.9 times, which is 17% below its historical average.
Share prices can rise and fall. Past performance does not guarantee future results. This article is news, not investment advice.
Newsletter
Markets in your inbox, weekly
LATAM-focused analysis, investing ideas, and the week in finance.
Keep reading